ஜென்ஸ் லண்ட்கிரென் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜென்ஸ் லண்ட்கிரென். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜென்ஸ் லண்ட்கிரென் Today - Breaking & Trending Today

Two Takes on a Pandemic


POLICY
Two Takes on a Pandemic
Every nation has had its own experience of COVID-19. The stories of Denmark,
a model of socialized care, and Rwanda, a bright spot among developing
nations, both hold wider lessons for the world.
by Linda Keslar //
Art by Image 1: Simon Wohlfahrt/Getty Images; Image 2: Claus Bjoern Larsen/Associated Press
IN SPRING 2020, WHEN the COVID-19 pandemic was first raging through sub-Saharan Africa, Hassan Nsabimana was among countless truck drivers who continued to work transporting essential cargo to Rwanda from neighboring countries. In a phone conversation last May from Tanzania, Nsabimana told his eldest son, Faycal Hassan Tuyishime, that he wasn’t feeling well and was heading home. “In his voice, you could tell he was critically ill,” Tuyishime says.  ....

United States , United Kingdom , South Korea , Trine Mogensen , Rahul Joseph , Faycal Hassan Tuyishime , Agnes Binagwaho , David Olagnier , Menelas Nkeshimana , Jens Lundgren , Hassan Nsabimana , Eli Cahan , University Of Copenhagen , University Of Rwanda , Global Health Security Index , Rwanda Medical Association , Danish Patient Safety Authority , Lowy Institute , University Hospital , University Of Global Health Equity , Community Vulnerability Index , European Union , University Of Kigali Hospital , Kigali International Airport , World Health Organization , Treatment Centre In Kan Yinya ,

COVID-19: What is monoclonal antibody therapy?


REGN-COV2: Casirivimab and imdevimab
On November 21, 2020, the FDA
authorized the emergency use of REGN-COV2 for mild-to-moderate COVID-19. The EMA have concluded that healthcare professionals can use this treatment for COVID-19 patients at risk of developing severe disease but who do not require oxygen treatment. The agency will continue their rolling review to support national health authorities in European Union countries, who issue authorization for use individually.
The NIH, on the other hand, have stated that there is not enough evidence to support its use and that there is a need to review phase 3 trial data, which were released on March 23, 2021. ....

United States , United Kingdom , South Africa , Russian Federation , Jens Lundgren , Donald Trump , Levilimab Ilsira , Pinterest Johnnygreig Getty , Remdesivir Veklury , Eli Lilly , Dmitry Morozov , Centers For Disease , University Of Copenhagen , National Institutes Of Health , Drug Administration , Russian Federation Ministry Of Health , Vaccine Initiative , European Union , European Medicines Agency , News Today , National Institutes , Drugs Controller General , Disease Control , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ரஷ்ய கூட்டமைப்பு ,